GenMark Diagnostics ROA 2010-2018 | GNMK

Current and historical return on assets (ROA) values for GenMark Diagnostics (GNMK) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. GenMark Diagnostics ROA for the three months ending June 30, 2018 was -50.38%.
GenMark Diagnostics Annual ROA
2017 -50.88
2016 -63.00
2015 -59.71
2014 -41.60
2013 -27.63
2012 -32.50
2011 -62.77
2010 -73.85
2009 0.00
GenMark Diagnostics Quarterly ROA
Q2 2018 -16.88
Q1 2018 -10.28
Q4 2017 -11.89
Q3 2017 -11.93
Q2 2017 -12.33
Q1 2017 -21.72
Q4 2016 -15.78
Q3 2016 -14.06
Q2 2016 -20.61
Q1 2016 -21.10
Q4 2015 -12.43
Q3 2015 -14.79
Q2 2015 -14.53
Q1 2015 -10.69
Q4 2014 -9.36
Q3 2014 -9.88
Q2 2014 -10.51
Q1 2014 -7.69
Q4 2013 -8.73
Q3 2013 -8.41
Q2 2013 -14.10
Q1 2013 -6.54
Q4 2012 -6.90
Q3 2012 -9.11
Q2 2012 -7.62
Q1 2012 -17.19
Q4 2011 -14.23
Q3 2011 -14.45
Q2 2011 -11.04
Q1 2011 -30.26
Q4 2010 -14.05
Q3 2010 -17.34
Q2 2010 -15.49
Q1 2010 0.00
Q4 2009 0.00
Q3 2009 0.00
Q2 2009 0.00
Q1 2009 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.424B $0.053B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $97.678B 23.43
Intuitive Surgical (ISRG) United States $63.833B 60.93
Fresenius Medical Care (FMS) Germany $31.779B 22.45
Edwards Lifesciences (EW) United States $31.716B 35.72
IDEXX Laboratories (IDXX) United States $20.957B 63.69
ABIOMED (ABMD) United States $17.142B 140.43
Teleflex (TFX) United States $12.366B 29.42
DexCom (DXCM) United States $12.318B 0.00
Hologic (HOLX) United States $11.203B 19.06
Varian Medical Systems (VAR) United States $10.224B 25.73
STERIS (STE) United Kingdom $9.661B 26.57
Masimo (MASI) United States $6.318B 42.07
LivaNova (LIVN) United Kingdom $5.879B 35.07
Inogen (INGN) United States $5.423B 143.50
Integra LifeSciences Holdings (IART) United States $5.397B 27.93
Penumbra (PEN) United States $5.202B 472.81
Globus Medical (GMED) United States $5.178B 34.44
Cantel Medical (CMD) United States $4.075B 42.48
Halyard Health (AVNS) United States $3.284B 27.02
Wright Medical Group (WMGI) Netherlands $2.991B 0.00
Integer Holdings (ITGR) United States $2.680B 24.26
Opko Health (OPK) United States $2.418B 0.00
Tandem Diabetes Care (TNDM) United States $2.297B 0.00
Glaukos (GKOS) United States $2.110B 1209.00
Nevro (NVRO) United States $1.788B 0.00
Mazor Robotics (MZOR) Israel $1.389B 0.00
AxoGen (AXGN) United States $1.380B 0.00
TransEnterix (TRXC) United States $1.350B 0.00
Luminex (LMNX) United States $1.330B 39.22
CryoLife (CRY) United States $1.250B 109.68
Accelerate Diagnostics (AXDX) United States $1.199B 0.00
K2Ms (KTWO) United States $1.190B 0.00
Tactile Systems Technology (TCMD) United States $1.182B 201.47
Natus Medical (BABY) United States $1.159B 24.57
Orthofix (OFIX) United States $1.014B 30.90
Intersect ENT (XENT) United States $0.888B 0.00
AngioDynamics (ANGO) United States $0.868B 32.08
ViewRay (VRAY) United States $0.738B 0.00
Mesa Laboratories (MLAB) United States $0.697B 43.10
Sientra (SIEN) United States $0.683B 0.00
Pacific Biosciences Of California (PACB) United States $0.640B 0.00
Neuronetics (STIM) United States $0.583B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.415B 0.00
OrthoPediatrics (KIDS) United States $0.400B 0.00
Quotient (QTNT) Switzerland $0.365B 0.00
Veracyte (VCYT) United States $0.351B 0.00
Accuray (ARAY) United States $0.337B 0.00
IRadimed (IRMD) United States $0.337B 121.35
Fluidigm (FLDM) United States $0.321B 0.00
Nuvectra (NVTR) United States $0.319B 0.00
CRH Medical (CRHM) Canada $0.294B 36.82
RTI Surgical (RTIX) United States $0.282B 55.63
T2 Biosystems (TTOO) United States $0.273B 0.00
Corindus Vascular Robotics (CVRS) United States $0.259B 0.00
Pulse Biosciences (PLSE) United States $0.243B 0.00
SeaSpine Holdings (SPNE) United States $0.229B 0.00
Helius Medical Technologies (HSDT) United States $0.229B 0.00
Invuity (IVTY) United States $0.177B 0.00
Apollo Endosurgery (APEN) United States $0.156B 0.00
Alphatec Holdings (ATEC) United States $0.136B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.130B 0.00
Ekso Bionics Holdings (EKSO) United States $0.127B 0.00
Second Sight Medical Products (EYES) United States $0.119B 0.00
Sensus Healthcare (SRTS) United States $0.115B 0.00
Viveve Medical (VIVE) United States $0.093B 0.00
EDAP TMS (EDAP) France $0.082B 0.00
Restoration Robotics (HAIR) United States $0.080B 0.00
ConforMIS (CFMS) United States $0.078B 0.00
Xtant Medical Holdings (XTNT) United States $0.060B 0.00
Neovasc (NVCN) Canada $0.053B 0.00
Electromed (ELMD) United States $0.049B 27.14
OBALON THERPTCS (OBLN) United States $0.047B 0.00
Vermillion (VRML) United States $0.044B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.042B 0.00
PAVmed (PAVM) United States $0.033B 0.00
ReWalk Robotics (RWLK) Israel $0.032B 0.00
Titan Medical (TMDI) Canada $0.031B 0.00
Lianluo Smart (LLIT) China $0.030B 0.00
Presbia (LENS) Ireland $0.027B 0.00
Dynatronics (DYNT) United States $0.025B 0.00
DarioHealth (DRIO) Israel $0.021B 0.00
Microbot Medical (MBOT) United States $0.018B 0.00
Nanovibronix (NAOV) United States $0.017B 0.00
American Shared Hospital Services (AMS) United States $0.017B 13.64
Avinger (AVGR) United States $0.017B 0.00
Bioanalytical Systems (BASI) United States $0.017B 0.00
ENDRA Life Sciences (NDRA) United States $0.013B 0.00
Micron Solutions (MICR) United States $0.010B 0.00
Allied Healthcare Products (AHPI) United States $0.009B 0.00
Cesca Therapeutics (KOOL) United States $0.009B 0.00
Sunshine Heart Inc (CHFS) United States $0.008B 0.00
Atossa Genetics (ATOS) United States $0.008B 0.00
InspireMD (NSPR) Israel $0.004B 0.00
Amedica (AMDA) United States $0.003B 0.00
EnteroMedics (RSLS) United States $0.000B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00